Repeated courses of Rituximab in chronic ITP: Three different regimens Journal Article


Authors: Hasan, A.; Michel, M.; Patel, V.; Stasi, R.; Cunningham Rundles, S.; Leonard, J. P.; Bussel, J.
Article Title: Repeated courses of Rituximab in chronic ITP: Three different regimens
Abstract: This study investigated responses to retreatment with rituximab in chronic immune thrombocytopenic purpura (ITP) patients. Treatment with rituximab in chronic ITP patients induces long-lasting responses in ∼30% of patients but even these patients may relapse. Twenty patients who had achieved a response to rituximab and relapsed were retreated with rituximab (375 mg/m<sup>2</sup>x 4); this data was analyzed retrospectively. Subsequently, 16 patients were prospectively randomized to receive rituximab with cyclophosphamide, vincristine and prednisone (R-CVP) or double dose rituximab (DDR). Retreatment with standard dose rituximab demonstrated responses similar to initial rituximab treatment in 15 of 20 patients. Neither of the two more intensive regimens (R-CVP, DDR) induced responses in any patient who had previously failed to respond to rituximab nor induced substantially longer-lasting responses among previous responders. No additional toxicity was noted with the DDR regimen, whereas R-CVP was not well tolerated. These results suggest that retreatment with standard dose rituximab induces similar responses in 75% of previously responding patients and is well tolerated. Neither combining rituximab with CVP nor doubling the dose of rituximab increased the response rate. © 2009 Wiley-Liss, Inc.
Keywords: clinical article; controlled study; prednisone; clinical trial; drug tolerability; cancer patient; rituximab; controlled clinical trial; multiple cycle treatment; randomized controlled trial; cyclophosphamide; vincristine; medical record review; retrospective study; chronic disease; drug response; cancer relapse; idiopathic thrombocytopenic purpura; allergic reaction; retreatment
Journal Title: American Journal of Hematology
Volume: 84
Issue: 10
ISSN: 0361-8609
Publisher: John Wiley & Sons, Inc.  
Date Published: 2009-01-01
Start Page: 661
End Page: 665
Language: English
DOI: 10.1002/ajh.21512
PROVIDER: scopus
PMCID: PMC2783818
PUBMED: 19731307
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 30 November 2010" - "CODEN: AJHED" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Aisha Nasreen Hasan
    56 Hasan
  2. James B Bussel
    8 Bussel